Bright Minds Biosciences Inc. (DRUG) PT Raised to $220 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi raised the price target on Bright Minds Biosciences Inc. (NASDAQ: DRUG) to $220.00 (from $190.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
